PUBLISHER: The Business Research Company | PRODUCT CODE: 1825680
PUBLISHER: The Business Research Company | PRODUCT CODE: 1825680
Cluster Headache Syndrome Global Market Report 2025
Cluster headache syndrome is a condition marked by severe, recurrent headaches that occur in clusters or episodes. These headaches are typically one-sided and extremely painful, often described as sharp, burning, or piercing sensations. They usually manifest around the eye or temple area and last between 15 minutes and three hours.
The main types of cluster headache syndrome are episodic and chronic. Episodic cluster headache features relatively long, pain-free remissions between headache episodes and is the more common type, affecting about 90% of those with the condition. Various medications used to treat cluster headaches include calcium channel blockers, corticosteroids, sumatriptan, lithium carbonate, ergots, melatonin, anti-seizure drugs, and local anesthetics. Diagnosis may involve neurological examination, magnetic resonance imaging (MRI), and computed tomography (CT) scans. Treatments can be administered orally, topically, intravenously, and through other methods, and are available through channels such as hospital pharmacies, retail pharmacies, online stores, and more.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The cluster headache syndromes market research report is one of a series of new reports from The Business Research Company that provides cluster headache syndromes market statistics, including cluster headache syndromes industry global market size, regional shares, competitors with a cluster headache syndromes market share, detailed cluster headache syndromes market segments, market trends, and opportunities, and any further data you may need to thrive in the cluster headache syndromes industry. This cluster headache syndromes research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cluster headache syndrome market size has grown strongly in recent years. It will grow from $0.8 billion in 2024 to $0.85 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to a rise in public health initiatives, growth in research and development for headache treatments, increasing awareness of neurological disorders, growth in multinational clinical trials, and a rise in the availability of supportive therapies.
The cluster headache syndrome market size is expected to see strong growth in the next few years. It will grow to $1.1 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to the rising prevalence of neurological disorders, rising investments in the development of new drugs, increasing healthcare spending, rising number of depression cases, and rising approval of drugs. Major trends in the forecast period include technological advancements, telemedicine, personalized medicine, neuromodulation techniques, and targeted drug therapies.
The forecast of 6.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. neurology care by inflating prices of high-flow oxygen therapy systems and sumatriptan autoinjectors developed in France and Switzerland, resulting in prolonged headache cycles and higher emergency department costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of neurological disorders is anticipated to drive the growth of the cluster headache syndrome market. Neurological disorders encompass a range of conditions affecting the nervous system, including the brain, spinal cord, and nerves throughout the body. The rise in neurological disorders is influenced by factors such as the growing prevalence of risk factors such as diabetes, improved diagnostic capabilities, neurological complications from other conditions, and socioeconomic disparities. Treatments for neurological disorders can help manage cluster headache syndrome, as some of these conditions overlap with or impact headache pathways. Addressing the symptoms and underlying factors of cluster headaches can effectively reduce their frequency, severity, and impact. For instance, in April 2022, the European Brain Council, a Belgium-based non-profit organization, reported that 10.5 million Europeans were affected by dementia (a neurological disorder), with this number expected to rise to 18.7 million by 2050. Therefore, the growing prevalence of neurological disorders is driving the cluster headache syndrome market.
Leading companies in the cluster headache syndrome market are focusing on developing advanced technologies, such as implantable neurostimulation systems, to offer more effective treatment options. Implantable neurostimulation technology involves surgically implanted devices that deliver electrical impulses to specific areas of the nervous system. For example, in August 2023, Salvia BioElectronics, a medical device company based in the Netherlands, introduced a paper-thin neuromodulation device designed to treat severe migraines and cluster headaches. This innovative device includes ultra-thin bioelectronic foils that adapt to the shape of the patient's head once implanted, delivering targeted electrical pulses. Since migraines and cluster headaches are associated with heightened sensitivity in certain brain areas, the electrical pulses provided by the device help restore balance and alleviate the headaches.
In October 2022, Emergex Vaccines Holding Limited, a UK-based biotechnology company, acquired the assets of Zosano Pharma Corporation, including intellectual property, license agreements, and manufacturing equipment, for an undisclosed amount. This acquisition enables Emergex to utilize Zosano's microneedle patch technology and manufacturing capabilities. Zosano Pharma Corporation is a US-based clinical-stage biopharmaceutical company specializing in developing treatments for cluster headache syndrome.
Major companies operating in the cluster headache syndrome market are Pfizer Inc., Bayer AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Hikma Pharmaceuticals, Amneal Pharmaceuticals, Grunenthal GmbH, Mallinckrodt Pharmaceuticals, Upsher-Smith Laboratories, Zogenix Inc., Neurelis Inc., ElectroCore Medical LLC, Ceruvia Lifesciences, TrioxBio Inc., Winston Pharmaceuticals Inc., Zosano Pharma Corporation, Autonomic Technologies Inc., H. Lundbeck A/S
North America was the largest region in the cluster headache syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cluster headache syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cluster headache syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cluster headache syndrome market consists of revenues earned by entities by providing services such as clinical services, specialized consultations, patient education programs, and support services. and related medical devices, microneedle patch technology, and diagnostic tools. The market value includes the value of related goods sold by the service provider or included within the service offering. The cluster headache syndrome market also includes sales of abortive medication, fast-acting analgesics, calcium channel blockers, corticosteroids, and anticonvulsants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
Reasons to Purchase
Scope
Table of Contents
1. Executive Summary
2. Cluster Headache Syndrome Market Characteristics
3. Cluster Headache Syndrome Market Trends And Strategies
4. Cluster Headache Syndrome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Cluster Headache Syndrome Growth Analysis And Strategic Analysis Framework
- 5.1. Global Cluster Headache Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Cluster Headache Syndrome Market Growth Rate Analysis
- 5.4. Global Cluster Headache Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Cluster Headache Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
6. Cluster Headache Syndrome Market Segmentation
7. Cluster Headache Syndrome Market Regional And Country Analysis
8. Asia-Pacific Cluster Headache Syndrome Market
9. China Cluster Headache Syndrome Market
10. India Cluster Headache Syndrome Market
11. Japan Cluster Headache Syndrome Market
12. Australia Cluster Headache Syndrome Market
13. Indonesia Cluster Headache Syndrome Market
14. South Korea Cluster Headache Syndrome Market
15. Western Europe Cluster Headache Syndrome Market
16. UK Cluster Headache Syndrome Market
17. Germany Cluster Headache Syndrome Market
18. France Cluster Headache Syndrome Market
19. Italy Cluster Headache Syndrome Market
20. Spain Cluster Headache Syndrome Market
21. Eastern Europe Cluster Headache Syndrome Market
22. Russia Cluster Headache Syndrome Market
23. North America Cluster Headache Syndrome Market
24. USA Cluster Headache Syndrome Market
25. Canada Cluster Headache Syndrome Market
26. South America Cluster Headache Syndrome Market
27. Brazil Cluster Headache Syndrome Market
28. Middle East Cluster Headache Syndrome Market
29. Africa Cluster Headache Syndrome Market
30. Cluster Headache Syndrome Market Competitive Landscape And Company Profiles
31. Cluster Headache Syndrome Market Other Major And Innovative Companies
32. Global Cluster Headache Syndrome Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Cluster Headache Syndrome Market
34. Recent Developments In The Cluster Headache Syndrome Market
35. Cluster Headache Syndrome Market High Potential Countries, Segments and Strategies
36. Appendix
